Insulin therapy in patients with COVID-19
Acta Diabetol
.
2022 Feb;59(2):285-286.
doi: 10.1007/s00592-021-01810-x.
Epub 2021 Oct 14.
Authors
Chia Siang Kow
1
2
,
Dinesh Sangarran Ramachandram
3
,
Syed Shahzad Hasan
4
5
Affiliations
1
School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. chiasiang_93@hotmail.com.
2
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang jaya, Selangor, Malaysia. chiasiang_93@hotmail.com.
3
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Subang jaya, Selangor, Malaysia.
4
School of Applied Sciences, University of Huddersfield, Huddersfield, UK.
5
School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, Australia.
PMID:
34648089
PMCID:
PMC8515914
DOI:
10.1007/s00592-021-01810-x
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Glucose
COVID-19*
Humans
Hypoglycemic Agents
Insulin*
SARS-CoV-2
Substances
Blood Glucose
Hypoglycemic Agents
Insulin